Portfolio company
Entia
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops at-home blood monitoring devices for cancer patients to share results with healthcare providers and improve treatment management.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Enzyre
This company develops a portable diagnostic device for haemophilia patients to monitor blood coagulation status and manage treatment from home.
LEUKO
This company develops a non-invasive device for monitoring white blood cell levels at home for cancer patients undergoing chemotherapy.
52 North
This company develops point-of-care diagnostic devices and digital tools for cancer patients to monitor life-threatening complications like neutropenic sepsis at home.
Luminate Medical
This company develops wearable medical devices to prevent chemotherapy side effects and facilitate at-home cancer treatment for oncology patients and healthcare providers.
Empo Health
This company produces an at-home imaging scale and monitoring service for diabetic patients to help prevent foot ulcers and amputations.
Resilience Care
This company develops a remote monitoring platform and mobile application for oncology, gastroenterology and psychiatry patients to personalise and improve care pathways.
Sanguina
This company develops digital health tools and home test kits that allow individuals to monitor their blood health and manage anaemia.
Astron Health
This company develops a precision oncology platform that provides molecular data analysis and personalised treatment reports for cancer patients and their clinicians.
